Medical Marijuana Stock Cannabis Science Inc. (CBIS) Soars in Tuesday’s Trading Session
Shares of Cannabis Science Inc. (OTC: CBIS), a medical marijuana company, surged in Tuesday’s trading session. The penny stock of CBIS ended the day 38.39% higher at $0.100. Despite the rally on Tuesday, CBIS shares are down more than 7% in the last three trading sessions.
At last check, the penny stock is down 5% to $0.0950 in today’s session.
Cannabis Science shares have been in focus over the last few days following a statement from House Minority Leader Nancy Pelosi to President Obama. In her statement, Nancy Pelosi supported the medical cannabis industry. She said that access to medical marijuana for individuals who are ill or enduring difficult and painful therapies is both a medical and states’ right issue.
Dr. Robert Melamede, CEO of Cannabis Science, said that he expects to continue to see more and more politicians come out in favor of the medical cannabis industry over the next few months.
- This newsletter has been helping traders make a killing on CBIS. Click here for a 25% discount offer.
- See today’s top stock picks and market analysis
- Need fast service and cheap rates from a broker? Buy stock online at my favorite brokerage
- Want more? Check out the message board buzz for CBIS
- See what newsletters are recommending this stock pick
- Get breaking news alerts on these stocks: http://thestockmarketwatch.com/
Posted by Mike Zaman
on Wednesday, May 9th, 2012. Filed under Internet, Technology.
You can follow any responses to this entry through the RSS 2.0.
You can leave a response or trackback to this entry
This newsletter is a paid advertisement and is neither an offer nor recommendation to buy or sell any security. We hold no investment licenses and are thus neither licensed nor qualified to provide investment advice. The content in this report or email is not provided to any individual with a view toward their individual circumstances. Tech24.org is a wholly-owned subsidiary of BlueWave Advisors.
While all information is believed to be reliable, it is not guaranteed by us to be accurate. Individuals should assume that all information contained in our newsletter is not trustworthy unless verified by their own independent research. Also, because events and circumstances frequently do not occur as expected, there will likely be differences between the any predictions and actual results. Always consult a real licensed investment professional before making any investment decision. Be extremely careful, investing in securities carries a high degree of risk; you may likely lose some or all of the investment.
© 2013